Trial investigates efficacy of online supervised group mental and physical rehabilitation program for long COVID patients

Researchers evaluated the efficacy of an online supervised group mental and physical rehabilitation program in adults with long COVID.

Celldex drug reduces chronic hive activity, but patient discontinuations raise questions

Celldex Therapeutics reported Wednesday that its experimental medicine for a condition that causes chronic hives reduced hive activity in patients, completely clearing it in some.

September 25, 2024

BWX Technologies to buy Canadian isotope maker for $525M

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 8, 2025

LVRNA009 mRNA vaccine shows long-term efficacy against SARS-CoV-2 variants

Announcing a new article publication for Zoonoses journal. The global coronavirus disease 2019 (COVID-19) pandemic was caused by SARS-CoV-2.

May 20, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.